Clinical Trial Update: Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating obecabtagene autoleucel as consolidation therapy in newly diagnosed high-risk B-cell acute lymphoblastic leukemia; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Obecabtagene Autoleucel

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphocytic Leukemia (ALL) | Phase 2 | Status: RECRUITING